Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Repurposing the selective estrogen receptor modulator bazedoxifene to suppress gastrointestinal cancer growth.
Thilakasiri P, Huynh J, Poh AR, Tan CW, Nero TL, Tran K, Parslow AC, Afshar-Sterle S, Baloyan D, Hannan NJ, Buchert M, Scott AM, Griffin MD, Hollande F, Parker MW, Putoczki TL, Ernst M, Chand AL. Thilakasiri P, et al. Among authors: parslow ac. EMBO Mol Med. 2019 Apr;11(4):e9539. doi: 10.15252/emmm.201809539. EMBO Mol Med. 2019. PMID: 30885958 Free PMC article.
Host IL11 Signaling Suppresses CD4+ T cell-Mediated Antitumor Responses to Colon Cancer in Mice.
Huynh J, Baloyan D, Chisanga D, Shi W, O'Brien M, Afshar-Sterle S, Alorro M, Pang L, Williams DS, Parslow AC, Thilakasiri P, Eissmann MF, Boon L, Masson F, Chand AL, Ernst M. Huynh J, et al. Among authors: parslow ac. Cancer Immunol Res. 2021 Jul;9(7):735-747. doi: 10.1158/2326-6066.CIR-19-1023. Epub 2021 Apr 27. Cancer Immunol Res. 2021. PMID: 33906864
The angiotensin receptor blocker, Losartan, inhibits mammary tumor development and progression to invasive carcinoma.
Coulson R, Liew SH, Connelly AA, Yee NS, Deb S, Kumar B, Vargas AC, O'Toole SA, Parslow AC, Poh A, Putoczki T, Morrow RJ, Alorro M, Lazarus KA, Yeap EFW, Walton KL, Harrison CA, Hannan NJ, George AJ, Clyne CD, Ernst M, Allen AM, Chand AL. Coulson R, et al. Among authors: parslow ac. Oncotarget. 2017 Mar 21;8(12):18640-18656. doi: 10.18632/oncotarget.15553. Oncotarget. 2017. PMID: 28416734 Free PMC article.
New insights into ErbB3 function and therapeutic targeting in cancer.
Hafeez U, Parslow AC, Gan HK, Scott AM. Hafeez U, et al. Among authors: parslow ac. Expert Rev Anticancer Ther. 2020 Dec;20(12):1057-1074. doi: 10.1080/14737140.2020.1829485. Epub 2020 Oct 26. Expert Rev Anticancer Ther. 2020. PMID: 32981377 Review.
Antibody-mediated delivery of therapeutics for cancer therapy.
Parakh S, Parslow AC, Gan HK, Scott AM. Parakh S, et al. Among authors: parslow ac. Expert Opin Drug Deliv. 2016;13(3):401-19. doi: 10.1517/17425247.2016.1124854. Epub 2015 Dec 19. Expert Opin Drug Deliv. 2016. PMID: 26654403 Review.
The site of breast cancer metastases dictates their clonal composition and reversible transcriptomic profile.
Berthelet J, Wimmer VC, Whitfield HJ, Serrano A, Boudier T, Mangiola S, Merdas M, El-Saafin F, Baloyan D, Wilcox J, Wilcox S, Parslow AC, Papenfuss AT, Yeo B, Ernst M, Pal B, Anderson RL, Davis MJ, Rogers KL, Hollande F, Merino D. Berthelet J, et al. Among authors: parslow ac. Sci Adv. 2021 Jul 7;7(28):eabf4408. doi: 10.1126/sciadv.abf4408. Print 2021 Jul. Sci Adv. 2021. PMID: 34233875 Free PMC article.
Antibody-Drug Conjugates for Cancer Therapy.
Parslow AC, Parakh S, Lee FT, Gan HK, Scott AM. Parslow AC, et al. Biomedicines. 2016 Jul 11;4(3):14. doi: 10.3390/biomedicines4030014. Biomedicines. 2016. PMID: 28536381 Free PMC article. Review.
Evolution of anti-HER2 therapies for cancer treatment.
Parakh S, Gan HK, Parslow AC, Burvenich IJG, Burgess AW, Scott AM. Parakh S, et al. Among authors: parslow ac. Cancer Treat Rev. 2017 Sep;59:1-21. doi: 10.1016/j.ctrv.2017.06.005. Epub 2017 Jul 6. Cancer Treat Rev. 2017. PMID: 28715775 Review.
22 results